Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,719.45 -227.48 (-0.58%) Hang Seng
19,326.25 +105.63 (+0.55%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,935.51 -1,331.13 (-1.87%) CMC Crypto 200
1,526.21 +37.67 (+2.53%)
Roche Holding AG (0TDF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:30PM BST
| Previous close | 32.91 |
| Open | 0.00 |
| Bid | 28.10 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 352 |
| Market cap | 2.25B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | 0.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Roche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
- Zacks
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
- Zacks
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.
© 2024 Yahoo. All rights reserved.